TABLE-Noile-Immune Biotech -2025 parent results

About this update from Noile-immune Biotech Inc.

Feb 13 (Reuters)- Noile-Immune Biotech Inc. PARENT-ONLY FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Dec 31, 2025 Dec 31, 2024 Dec 31, 2026 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 5 mln 7 mln (-34.1 pct) (-97.6 pct) Operating loss 797 mln loss 1.07 Recurring loss 791 mln loss 962 mln Net loss 793 mln loss 964 mln EPS loss 18.33 yen loss 22.28 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - Noile-Immune Biotech Inc.. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4893.T

View stock analysis, news, and events for Noile-immune Biotech Inc.